Therapeutic options for intermediate-advanced hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34771990

about

Liver resection for intermediate hepatocellular carcinoma Hepatic resection beyond barcelona clinic liver cancer indication: When and how Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights Recent advances in multidisciplinary management of hepatocellular carcinoma Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.Quantification of dynamic contrast-enhanced ultrasound in HCC: prediction of response to a new combination therapy of sorafenib and panobinostat in advanced hepatocellular carcinoma.Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials Intermediate hepatocellular carcinoma: current treatments and future perspectives.Treatment of hepatocellular carcinoma: a systematic review.Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.Appropriate surgical therapy for patients with hepatocellular carcinoma beyond Milan criteria.Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells.Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).Assessment of the Hong Kong Liver Cancer Staging System in Europe.Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma.Interventionelle Therapie von Lungen- und Lebermetastasen Interventionelle Therapie primärer Lebertumoren

P2860

Q26748756-AD726C3E-DD95-4E45-879B-C01DF3645BE8 Q26751300-23B36E1B-62B0-41C2-92D8-A27FE265CC95 Q26784407-3A121EF4-0418-4545-98B4-894DEAF018A6 Q26799928-EC8949DA-4D9C-4B24-9782-FB2CF09B8A85 Q26863748-E0391583-BD12-456F-9456-08ED06D2C7A8 Q30472126-3364C1D1-3F4C-439F-BB7D-5DC5B5E8A143 Q34388854-56991E2D-FFF9-47AF-BA82-830A98F53559 Q35209230-8E6EFA49-D776-422E-9FEA-80CBBBB19EA7 Q35626764-9DAD79A0-CE95-48DB-BFD8-C0296DDD2CCB Q35872118-5C4F6C32-0D0B-4538-A56E-59F353377A2C Q35979637-54AED593-0E16-46E4-9786-EA7710754AC6 Q36151948-37B41C4F-311E-4CA9-9379-996757A161BE Q36208355-701DD2E5-F9E9-4A57-811E-01DD6F92BAA0 Q37061945-9B2472AF-ECC4-4E36-85FD-5F8224508C16 Q38110203-8E3B03FA-78A9-42BD-AF36-278792D0CF19 Q38155508-291FCF42-E621-4E07-98C3-52CB782CFA73 Q38460881-1CA2870C-3B6B-4F4B-A206-8F7786CB374A Q39153997-66DDC2B4-FDFF-4F44-A491-5D1AD6245707 Q45941592-7B8ABDDD-EBDA-4E22-B7B9-91DBA82EB671 Q46985663-8C8A5C7C-A270-49B9-AA52-1CA691894FA1 Q48368428-20500051-F666-4B34-9C11-556B29EE54F6 Q50434131-80EE2CD1-ADD0-4E2B-AA43-FAC30E187662 Q52885569-6BF74406-E832-4BAC-BEF5-5E3292699EC4 Q58904316-B736DA6F-13E6-4223-A15A-1C78A84AEFAB Q58904357-579866A5-E5F6-4D52-9DE3-66B377D88361

P2860

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34771990

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@ast

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@en

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@nl

type

label

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@ast

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@en

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@nl

prefLabel

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@ast

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@en

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@nl

P1433

Q34771990-C1EADE19-E9CD-47B9-AD43-EE2E17F2D356

P1476

Q34771990-A6992D1F-A32B-443F-995E-847EB6ED659A

P2093

Q34771990-340E5234-DC82-400D-A7EE-212CE2E35545

Q34771990-4C030318-113C-4E4D-8801-1987D9699793

Q34771990-824553D4-8DFA-4EBA-8A97-6EF93B201EBC

Q34771990-B786A3AC-715A-4E2A-A07C-552D2578AF47

Q34771990-B9038DB7-B219-44AE-85B6-01FB275C20C2

Q34771990-DB1AD434-A4E5-4B7A-A11D-A12CAF8F3341

P2860

Q34771990-03F13180-931C-4F32-9773-97ADBB7302CD

Q34771990-048D5DA3-9820-4502-8B30-730A58EA8175

Q34771990-1CEC9421-E591-4CFC-940F-314F3059BCE7

Q34771990-1F9C87B8-CDBA-4CCA-975E-7EFE20E61E5F

Q34771990-37504F35-F79C-490B-968F-8F36D7DF6972

Q34771990-3BBAC1D2-6656-4C56-8C8E-70955E4C0C68

Q34771990-3C41EA4D-919E-4981-A043-8A818AD3C9F9

Q34771990-40195C8A-258A-4ACB-87F6-66CE6118C788

Q34771990-4698C62C-9FE1-4056-A51B-3A9D28E38585

Q34771990-4D489914-93C8-4EDD-BAC3-B4560B570C14

P304

Q34771990-B0B95B74-12FD-4CD2-8F17-2ADA17A9907B

P31

Q34771990-32E656FE-41D4-4E53-A14D-BEEE2465E42D

P356

Q34771990-8E1A1655-6F77-4627-8853-6FA3C11878AB

P407

Q34771990-7DDBEFE2-CE7A-4219-9F63-C5EDEF51FF12

P433

Q34771990-6AEC6E0D-E6D5-4F8D-93C6-05FA22CE34BB

P478

Q34771990-D16E3EEA-01A8-4518-BFD7-46341C2B5FAC

P577

Q34771990-6F223751-536D-473D-BC74-AEAD35C98D89

P5875

Q34771990-480908D3-BC3C-42C1-A596-FC81C1BF1C20

P698

Q34771990-F6D61A40-1168-4A79-9C76-585558294495

P932

Q34771990-8BE99159-233A-4B4D-BFA6-AFB73B8625A1

P356

WJG.V17.I13.1685

P1433

World Journal of Gastroenterology

P1476

Therapeutic options for intermediate-advanced hepatocellular carcinoma.

@en

P2093

Jin-Xing Guo

http://www.w3.org/2001/XMLSchema#string

Li-Jie Pan

http://www.w3.org/2001/XMLSchema#string

Nan Jiang

http://www.w3.org/2001/XMLSchema#string

Zhen-Ya Zhang

http://www.w3.org/2001/XMLSchema#string

Zi-Chao Zhang

http://www.w3.org/2001/XMLSchema#string

Zong-Ming Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sorafenib in advanced hepatocellular carcinoma

Sorafenib: a review of its use in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Technologies for ablation of hepatocellular carcinoma.

Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies.

Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes

An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus

P304

1685-1689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I13.1685

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51042392

http://www.w3.org/2001/XMLSchema#string

P698

21483627

http://www.w3.org/2001/XMLSchema#string

P932

3072631

http://www.w3.org/2001/XMLSchema#string